AAAAAA

   
Results: 1-11 |
Results: 11

Authors: MCCLUNG M CLEMMESEN B DAIFOTIS A GILCHRIST NL EISMAN J WEINSTEIN RS FULEIHAN GE REDA C YATES AJ RAVN P
Citation: M. Mcclung et al., ALENDRONATE PREVENTS POSTMENOPAUSAL BONE LOSS IN WOMEN WITHOUT OSTEOPOROSIS - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 128(4), 1998, pp. 253

Authors: ELHAJJFULEIHAN G LUCKEY M BAUER R WASNICH R KRUPA D REDA C YATES AJ DAIFOTIS A
Citation: G. Elhajjfuleihan et al., EFFECTS OF DISCONTINUATION OF ALENDRONATE IN EARLY POSTMENOPAUSAL WOMEN, Journal of bone and mineral research, 12, 1997, pp. 164-164

Authors: WEISS S MCCLUNG M GILCHRIST N RODRIGUEZ JA RAVN P YATES AJ KRUPA D REDA C
Citation: S. Weiss et al., 5-YEAR EFFICACY AND SAFETY OF ORAL ALENDRONATE FOR PREVENTION OF OSTEOPOROSIS IN EARLY POSTMENOPAUSAL WOMEN, Journal of bone and mineral research, 12, 1997, pp. 165-165

Authors: MCCLUNG M WASNICH R HOSKING D RAVN P REDA C FREEDHOLM D DAIFOTIS A
Citation: M. Mcclung et al., SAFETY OF ORAL ALENDRONATE 5 MG IN OSTEOPOROSIS PREVENTION, Journal of bone and mineral research, 12, 1997, pp. 464-464

Authors: CHAVASSIEUX PM ARLOT ME REDA C WEI L YATES AJ MEUNIER PJ
Citation: Pm. Chavassieux et al., HISTOMORPHOMETRIC ASSESSMENT OF THE LONG-TERM EFFECTS OF ALENDRONATE ON BONE QUALITY AND REMODELING IN PATIENTS WITH OSTEOPOROSIS, The Journal of clinical investigation, 100(6), 1997, pp. 1475-1480

Authors: SIRIS E WEINSTEIN RS ALTMAN R CONTE JM FAVUS M LOMBARDI A LYLES K MCILWAIN H MURPHY WA REDA C RUDE R SETON M TIEGS R THOMPSON D TUCCI JR YATES AJ ZIMERING M
Citation: E. Siris et al., COMPARATIVE-STUDY OF ALENDRONATE VERSUS ETIDRONATE FOR THE TREATMENT OF PAGETS-DISEASE OF BONE, The Journal of clinical endocrinology and metabolism, 81(3), 1996, pp. 961-967

Authors: ADAMI S PASSERI M ORTOLANI S BROGGINI M CARRATELLI L CARUSO I GANDOLINI G GNESSI L LAURENZI M LOMBARDI A NORBIATO G PRYORTILLOTSON S REDA C ROMANINI L SUBRIZI D WEI L YATES AJ
Citation: S. Adami et al., EFFECTS OF ORAL ALENDRONATE AND INTRANASAL SALMON-CALCITONIN ON BONE MASS AND BIOCHEMICAL MARKERS OF BONE TURNOVER IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS, Bone, 17(4), 1995, pp. 383-390

Authors: EISMAN JA CHRISTIANSEN C MCCLUNG M GILCHRIST N LUCKEY M HALE E REDA C DAIFOTIS A
Citation: Ja. Eisman et al., ALENDRONATE PREVENTS BONE LOSS AT THE SPINE AND HIP IN RECENTLY POSTMENOPAUSAL WOMEN, Journal of bone and mineral research, 10, 1995, pp. 176-176

Authors: ARLOT MC MEUNIER PJ CHAVASSIEUX P RECKER R REDA C WEI L YATES AJ
Citation: Mc. Arlot et al., EFFECTS OF LONG-TERM ALENDRONATE TREATMENT FOR POSTMENOPAUSAL OSTEOPOROSIS ON BONE HISTOMORPHOMETRY, Journal of bone and mineral research, 10, 1995, pp. 199-199

Authors: REDA C QUARESIMA T PASTORIS MC
Citation: C. Reda et al., IN-VITRO ACTIVITY OF 6 INTRACELLULAR ANTIBIOTICS AGAINST LEGIONELLA-PNEUMOPHILA STRAINS OF HUMAN AND ENVIRONMENTAL ORIGIN, Journal of antimicrobial chemotherapy, 33(4), 1994, pp. 757-764

Authors: AUBRY I ARNAUD B REDA C BLANCMARTIN C PERAY P FRAIMOUT JL
Citation: I. Aubry et al., CONTACT TRANSSCLERAL CYCLOPHOTOCOAGULATIO N - MIDTERM RESULTS, Journal francais d'ophtalmologie, 17(5), 1994, pp. 325-330
Risultati: 1-11 |